BNTX BioNTech SE Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

BNTX [NASD]

BioNTech SE

Healthcare | Biotechnology | Germany

statements

Index	-	P/E	-	EPS (ttm)	-0.58	Insider Own	1.26%	Shs Outstand	213.17M	Perf Week	18.73%
Market Cap	16.58B	Forward P/E	147.03	EPS next Y	0.53	Insider Trans	0.00%	Shs Float	50.34M	Perf Month	60.04%
Income	-130.30M	PEG	-	EPS next Q	-0.23	Inst Own	3.30%	Short Float	6.51%	Perf Quarter	86.48%
Sales	153.60M	P/S	107.95	EPS this Y	-300.50%	Inst Trans	0.70%	Short Ratio	1.67	Perf Half Y	96.02%
Book/sh	-	P/B	-	EPS next Y	158.00%	ROA	-	Target Price	42.78	Perf Year	-
Cash/sh	2.52	P/C	30.90	EPS next 5Y	-	ROE	-	52W Range	12.52 - 105.00	Perf YTD	129.57%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-31.40%	52W High	-25.92%	Beta	-
Dividend %	-	Quick Ratio	3.70	Sales past 5Y	-	Gross Margin	88.30%	52W Low	521.00%	ATR	5.55
Employees	1179	Current Ratio	3.70	Sales Q/Q	5.80%	Oper. Margin	-	RSI (14)	73.93	Volatility	7.74% 8.66%
Optionable	Yes	Debt/Eq	0.21	EPS Q/Q	-	Profit Margin	-	Rel Volume	4.61	Prev Close	77.78
Shortable	Yes	LT Debt/Eq	0.16	Earnings	May 12 BMO	Payout	-	Avg Volume	1.97M	Price	77.78
Recom	2.60	SMA20	27.85%	SMA50	43.63%	SMA200	100.25%	Volume	0	Change	0.00%

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Jul-14-20 08:27AM	Pfizer/BioNTech's Coronavirus Vaccine Gets FDA Fast Track Tag Zacks
07:42AM	FDA Aims to Fast-Track Coronavirus Vaccine: 3 Stocks in Focus Zacks
Jul-13-20 04:46PM	Stock Market Today: This Is Your Market on (Coronavirus) Drugs Kiplinger +10.55%
04:44PM	Pfizer and BioNTech Get "Fast Track" Designation for 2 COVID-19 Vaccines Motley Fool
04:29PM	Pfizer, BioNTech Pop After Coronavirus Vaccines Nab Speedy Review Investor's Business Daily
03:25PM	Coronavirus latest: Monday, July 13 Yahoo Finance Video
02:30PM	Los Angeles Schools Go Remote; Arizona Cases Slow: Virus Update Bloomberg
12:51PM	Pfizer, BioNTech get vaccine 'fast track' from FDA Reuters Videos
12:03PM	Hope for a Vaccine and Strong Earnings Is Sending Stocks Higher Barrons.com
11:31AM	Why BioNTech Stock Is Soaring Today Motley Fool
09:44AM	Pfizer, BioNTech Are Surging Because the FDA Fast Tracked Their Covid-19 Vaccines Barrons.com
08:58AM	Stock-index futures rise as investors prepare for earnings season kickoff, weigh vaccine news MarketWatch
07:48AM	Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status Reuters
06:57AM	Pfizer, BioNTech stocks surge after COVID-19 vaccine candidates get Fast Track designation MarketWatch
06:45AM	Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2 GlobeNewswire
Jul-12-20 01:02PM	2 Healthcare IPOs Getting a Tailwind From COVID-19 to Consider Buying Motley Fool
06:12AM	3 Top Healthcare Stocks to Buy Right Now Motley Fool
Jul-10-20 07:18PM	Atlanta Mayor Says City Will Roll Back to Phase 1 of Reopening Barrons.com +7.24%
02:34PM	Pfizer and BioNTech's Coronavirus Vaccine Ready for Regulatory Submission in December, Maybe Earlier Motley Fool
09:54AM	BioNTech to Seek Covid-Vaccine Regulatory Clearance in 2020 TheStreet.com
09:32AM	BioNTechs CEO Strikes Sober Note Amid Vaccine Scramble, While Warning It Could Take a Decade to Beat Covid-19 Barrons.com
Jul-08-20 10:05AM	Here's Why BioNTech Gained 34.8% in June Motley Fool
Jul-07-20 06:45AM	Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy? Motley Fool +5.85%
Jul-04-20 09:25AM	After months of speculation, investors get excited about Pfizer, BioNTechs coronavirus vaccine candidate MarketWatch
Jul-02-20 12:34PM	European stocks surge as U.S. economy adds 4.8 million jobs in June MarketWatch
11:05AM	Pfizer Reports Encouarging Data From Coronavirus Program Zacks
09:32AM	What could save the stock market in July? More government borrowing and Federal Reserve money printing MarketWatch
09:09AM	Pfizer Stock Rises as Company Unveils Aggressive Timeline for Coronavirus Vaccine Barrons.com
08:42AM	Implied Volatility Surging for BioNTech (BNTX) Stock Options Zacks
06:21AM	Coronavirus update: U.S. case tally climbs above 2.6 million, and top Republicans now call on Americans to wear face masks MarketWatch
Jul-01-20 11:41PM	Asian markets rise on vaccine hopes, signs of improving global economy MarketWatch
08:13PM	Gold Down Over Hopes For a COVID-19 Vaccine Investing.com
06:07PM	Why Pfizer Stock Rose Today Motley Fool
03:18PM	Coronavirus latest: Wednesday, July 1 Yahoo Finance Video
02:36PM	Pfizer and BioNTech Post Positive Trial Data for Their COVID-19 Vaccine Motley Fool
01:21PM	Pfizer, BioNTech Report Promising Initial Data From Coronavirus Vaccine Study Benzinga
11:54AM	Why Moderna Shares Are Sliding Today Motley Fool
11:06AM	Dow Turns Losses Into Gains After Pfizer Releases Vaccine Data Barrons.com
10:52AM	Virus Shot From Pfizer, BioNtech Shows Promise in Early Test Bloomberg
10:21AM	Pfizer Offers Hope, and Details, on Potential Coronavirus Vaccine Barrons.com
10:18AM	ADP Gains 2.37M Jobs, Pfizer's COVID Drug Passes Test Zacks
10:08AM	Economic Data Deluge Zacks
09:36AM	BioNTech's stock halted, Pfizer shares jump on promising COVID-19 vaccine data MarketWatch
09:28AM	BioNTech to Hold Webcast to Present Early Positive Data from Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2 GlobeNewswire
09:25AM	COVID-19 vaccine candidates with early human-trial data Reuters
09:19AM	BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial Reuters
09:01AM	Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2 GlobeNewswire
08:59AM	Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 Business Wire
Jun-30-20 09:19PM	BioNTech and Pfizers Covid-19 vaccine trial yields positive results Financial Times
08:47AM	BioNTech (BNTX) Looks Good: Stock Adds 5.9% in Session Zacks
Jun-29-20 02:06PM	Race for a COVID-19 vaccine has drug makers scaling up manufacturing before one is developed MarketWatch +5.91%
06:08AM	Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech Reuters
03:00AM	BioNTech to Raise USD 250 Million in Private Placement GlobeNewswire
Jun-25-20 11:43AM	Moderna Is the Latest Coronavirus Vaccine Partner for Catalent Barrons.com +9.10%
09:53AM	DJIA Today, Stocks Start Mixed After Jobless Data, As Covid Concerns Weigh; Boeing Downgraded, Nike Slips Ahead Of Q4 Report Investor's Business Daily
Jun-23-20 10:28AM	Translate Bio Stock Up 50% as Sanofi Commits $1.9 Billion to Its Covid-19 Vaccine Barrons.com -8.18%
Jun-18-20 06:18PM	CureVac to Work With Bank of America, Jefferies on IPO Bloomberg
Jun-17-20 10:14AM	CureVac's experimental coronavirus vaccine Reuters
Jun-16-20 01:18PM	Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany - sources Reuters
12:06PM	Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded Barrons.com
Jun-15-20 12:18PM	Germany Moves to Secure Stake in Virus Vaccine Developer Bloomberg
11:45AM	Germany Makes a Big Bet On a Covid-19 Vaccine Developer Once Coveted by Trump Barrons.com
11:37AM	Germany investing in coronavirus vaccine maker that it accused the Trump administration of trying to poach MarketWatch
Jun-13-20 06:22AM	Is BioNTech Stock a Buy? Motley Fool
Jun-12-20 12:31PM	Hedge Funds Are Nibbling On BioNTech SE (BNTX) Insider Monkey
Jun-11-20 08:23AM	Moderna Will Start Testing Its Covid-19 Vaccine on 30,000 People in July Barrons.com
03:00AM	Investment Plan for Europe: European Investment Bank to provide BioNTech with up to 100 million in debt financing for COVID-19 vaccine development and manufacturing GlobeNewswire
Jun-08-20 07:55AM	Drugmakers Target Coronavirus Vaccine in 2020: 4 Stocks in Focus Zacks
Jun-07-20 07:02AM	Is Moderna Really the Leader in the COVID-19 Vaccine Race? Motley Fool
Jun-05-20 11:59AM	Dont Judge Pfizer by Its Vaccine Efforts InvestorPlace
Jun-03-20 03:07PM	NYT: Trump identifies five drugmakers most likely to produce a viable COVID-19 vaccine MarketWatch
Jun-01-20 08:57AM	How BioNTech (BNTX) Stock Stands Out in a Strong Industry Zacks +5.59%
07:47AM	Drugmakers Focus on Coronavirus Vaccine by 2020: 4 Winners Zacks
May-31-20 07:32AM	Here's the Under-the-Radar Biotech That Could Beat Moderna at Its Own Game Motley Fool
May-29-20 09:59AM	Dow Jones Today, Stocks Open Mixed Ahead Of Trump China Remarks; Coronavirus Vaccine Stocks Rise, Zscaler Spikes On Earnings Investor's Business Daily +5.68%
May-28-20 11:34AM	ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic' Yahoo Finance
May-26-20 10:52AM	The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, Sanofi and GlaxoSmithKline Zacks
09:59AM	Novavax and Merck Fuel COVID-19 Vaccine Hopes Investopedia
May-22-20 07:29AM	Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus MarketWatch
May-21-20 05:51PM	BioNTechs COVID-19 Vaccine Program Has a Leg Up on Modernas, Says Analyst TipRanks
May-20-20 08:11AM	Better Buy: GlaxoSmithKline vs. Pfizer Motley Fool
May-19-20 06:50PM	U.S. Cases Rise 1.6%; N.Y. Allows Hospital Visits: Virus Update Bloomberg -15.92%
11:39AM	A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals Barrons.com
May-18-20 11:20AM	Who Is Winning the COVID-19 Vaccine Race? Investopedia +21.58%
May-15-20 07:16PM	Inside the Science and Companies Racing to Develop a Covid-19 Vaccine Barrons.com
May-14-20 11:51AM	Coronavirus Vaccine Progress Accelerates Yahoo Finance
08:13AM	Earnings Update: BioNTech SE (NASDAQ:BNTX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts Simply Wall St.
May-13-20 03:29AM	H.C. Wainwright Sticks to Their Hold Rating for BioNTech SE Investing.com
01:00AM	BioNTech SE (BNTX) Q1 2020 Earnings Call Transcript Motley Fool
May-09-20 01:23PM	Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine Motley Fool
May-06-20 04:15PM	BioNTech Completes Acquisition of Neon Therapeutics GlobeNewswire
03:34PM	Trumps coronavirus task force shifts focus to vaccines and reopening Yahoo Finance Video
02:15PM	BioNTech (BNTX) Stock Could Stay Grounded For Now SmarterAnalyst
May-05-20 04:26PM	Pfizer and BioNTech announce the start of BNT162 vaccine trial Yahoo Finance Video +9.22%
04:13PM	Covid Report: Pfizer Begins Vaccine Study; Test Maker Surges On Demand Investor's Business Daily
02:58PM	Pfizer Begins Human Testing Of Coronavirus Vaccine In US, Michigan Among Manufacturing Centers Benzinga
02:01PM	Pfizer and BioNTech Begin U.S. Trials of SARS-CoV-2 Vaccine Candidate Motley Fool
01:06PM	Pfizer, BioNTech Shares Rise on U.S. Coronavirus Vaccine Trial Start SmarterAnalyst
11:10AM	Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine TheStreet.com
10:11AM	Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial Reuters

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/II trial for prostate cancer; BNT113, which is in Phase I trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116, which is in preclinical trail for non-small cell lung cancer. It also develops individualized neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; and next-generation checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc., Sanofi S.A., Genmab A/S, Genevant Sciences GmbH, Eli Lilly and Company, Bayer AG, Pfizer Inc., and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. The company was founded in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience